Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of use
US-12384851-B2 · Aug 12, 2025 · US
This page is not indexed by search engines while we improve data quality.
Wei Ronnie patents
Wei Ronnie is listed as an inventor on 52 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Wei Ronnie |
| Total patents | 52 |
| First publication | Jan 21, 2016 |
| Latest publication | Aug 12, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Trispecific binding proteins, methods, and uses thereof
US-2025250337-A1 · Aug 7, 2025 · US
Trispecific binding proteins, methods, and uses thereof
US-2025250338-A1 · Aug 7, 2025 · US
Proteins binding NKG2D, CD16 and a tumor-associated antigen
US-12378318-B2 · Aug 5, 2025 · US
Multi-specific binding proteins that bind her2, nkg2d, and cd16, and methods of use
US-2025206827-A1 · Jun 26, 2025 · US
Multi-specific binding proteins that bind cd33, nkg2d, and cd16, and methods of use
US-2025154261-A1 · May 15, 2025 · US
Multi-specific binding proteins that bind HER2, NKG2D, and CD16, and methods of use
US-12275791-B2 · Apr 15, 2025 · US
Trispecific binding proteins, methods, and uses thereof
US-12227573-B2 · Feb 18, 2025 · US
Multi-specific binding proteins that bind CD33, NKG2D, and CD16, and methods of use
US-12215157-B2 · Feb 4, 2025 · US
Inhibitors of t-cell activation
US-2025002578-A1 · Jan 2, 2025 · US
Recent patents
Latest publications not already listed above.
Antigenic OspA Polypeptides
US-2024417432-A1 · Dec 19, 2024 · US
Trispecific and/or trivalent binding proteins
US-2024279362-A1 · Aug 22, 2024 · US
Inhibitors of T-cell activation
US-12043665-B2 · Jul 23, 2024 · US
Antigenic OspA polypeptides
US-11993636-B2 · May 28, 2024 · US
Proteins binding nkg2d, cd16 and flt3
US-2024117054-A1 · Apr 11, 2024 · US
Trispecific and/or trivalent binding proteins
US-11932704-B2 · Mar 19, 2024 · US
Trispecific anti-cd38, anti-cd28, and anti-cd3 binding proteins and methods of use for treating viral infection
US-2023357401-A1 · Nov 9, 2023 · US
Fgfr3 antibodies and methods of use
US-2023303704-A1 · Sep 28, 2023 · US
Trispecific binding proteins, methods, and uses thereof
US-2023220079-A1 · Jul 13, 2023 · US
Trispecific binding proteins, methods, and uses thereof
US-11613576-B2 · Mar 28, 2023 · US
Trispecific anti-CD38, anti-CD28, and anti-CD3 binding proteins and methods of use for treating viral infection
US-11530268-B2 · Dec 20, 2022 · US
Multi-specific binding proteins that bind cd33, nkg2d, and cd16, and methods of use
US-2022380459-A1 · Dec 1, 2022 · US
FGFR3 antibodies and methods of use
US-11505611-B2 · Nov 22, 2022 · US
Pharmaceutical formulations and dosage regimens for multi-specific binding proteins that bind her2, nkg2d, and cd16 for cancer treatment
US-2022195065-A1 · Jun 23, 2022 · US
Proteins binding nkg2d, cd16 and a tumor-associated antigen
US-2022153848-A1 · May 19, 2022 · US
Trispecific and/or trivalent binding proteins
US-2022119553-A1 · Apr 21, 2022 · US
Multi-specific binding proteins that bind bcma, nkg2d and cd16, and methods of use
US-2022089760-A1 · Mar 24, 2022 · US
Fgfr3 antibodies and methods of use
US-2022056142-A1 · Feb 24, 2022 · US
Multispecific binding molecules having specificity to dystroglycan and laminin-2
US-11254737-B2 · Feb 22, 2022 · US
Inhibitors of t-cell activation
US-2021380686-A1 · Dec 9, 2021 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Sanofi Sa | 26 |
| Genzyme Corp | 13 |
| Dragonfly Therapeutics Inc | 12 |
| The Usa As Represented By The Sec Dep Of Health And Human Services | 2 |
| The Us Secretary Department Of Health And Human Servic | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K2039/505 | 41 |
| C07K2317/92 | 38 |
| C07K2317/565 | 37 |
| A61P35/00 | 37 |
| C07K2317/31 | 36 |